AdaptHealth Corp. (AHCO) company profile
Close on Nov 17, 2026Market cap $1.03BP/E –Yield –
About AdaptHealth
Services-Home Health Care Services, SIC 8082
AdaptHealth Corp. provides home healthcare solutions, medical equipment, and related supplies directly to patients. The company operates through four reportable segments: Sleep Health, Respiratory Health, Diabetes Health, and Wellness at Home. Its offerings include sleep therapy devices, oxygen and mechanical ventilation systems, continuous glucose monitors, insulin pumps, and home medical supplies for individuals managing chronic conditions or recovering after hospital discharge. Its customer base consists of patients covered by Medicare, Medicaid, and commercial health insurance plans, receiving referrals from hospitals, specialized clinics, and physicians.
The company operates across the United States, delivering products and services to approximately 4.3 million patients annually in all 50 states. Its distribution network comprises roughly 640 leased facilities located across 48 states, supported by approximately 10,900 employees who complete an average of 38,500 daily deliveries. AdaptHealth maintains its principal executive offices in Conshohocken, Pennsylvania.
Summary of the business section of AdaptHealth's latest annual report, written by StockData.
Company profile
Company
- Legal name
- AdaptHealth Corp.
- Headquarters
- Conshohocken, PA
- Address
- 555 East North Lane, Suite 5075 19428
- Phone
- (610) 424-4515
- Website
- adapthealth.com
- Employees
- 10,900, Dec 31, 2025
- Industry
- Services-Home Health Care Services
- Incorporated in
- Delaware
- Fiscal year ends
- December 31
- Auditor
- KPMG LLP, Philadelphia, Pennsylvania
Stock & identifiers
- Ticker
- AHCO
- Exchange
- Nasdaq
- IPO date
- Feb 15, 2018
- Shares outstanding
- 136M, Jul 31, 2026
- Public float
- $1.04B, Jun 30, 2025
- Filer category
- Large accelerated filer
- SEC CIK
- 1725255
- CUSIP
- 00653Q102
- ISIN
- US00653Q1022
- FIGI
- BBG00KJQVGV3
- Share class FIGI
- BBG00KJQVGW2
- LEI
- 549300SN58QQ28RVWE26
- EIN
- 82-3677704
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Suzanne Foster | Chief Executive Officer, Director | 924,050 |
| Harriss T. Currie | CHIEF FINANCIAL OFFICER | 0 |
| III Russell E. Schuster | Chief Commercial Officer | 125,263 |
| Daniel Edward McFadden | Chief Operating Officer | 103,376 |
| Albert A. Prast | Chief Technology Officer | 338,712 |
| Richard W. Rew II | CLO and General Counsel | 107,097 |
| Christine E. Archbold | Chief Accounting Officer | 107,198 |
| Toby Scott Barnhart | Chief Operating Officer | 220,654 |
| Jason A. Clemens | Chief Financial Officer | 673,481 |
| Dale B. Wolf | Director | 177,234 |
| Kenneth A. Samet | Director | 48,569 |
| David Solomon Williams III | Director | 64,044 |
| Bradley J. Coppens | Director | 96,345 |
| Theodore B. Lundberg | Director | 892,495 |
| Terence J. Connors | Director | 95,262 |
| Gregory Belinfanti | Director | 104,269 |
| Susan T. Weaver | Director | 113,817 |
| Diana L. Nole | Director | 33,045 |
CEO pay and shareholder return
Pay versus performance table from the proxy statement
| Fiscal year | CEO total pay | CEO pay actually paid | Other executives (avg) | Value of $100 invested | Peer group |
|---|---|---|---|---|---|
| FY2025 | $10.26M | $9.60M | $3.42M | $27 | $110 |
| FY2024 Mr Richard Barasch | $2.07M | $2.06M | $4.12M | $25 | $93 |
| FY2024 Ms.Suzanne Foster | $8.39M | $8.35M | $4.12M | $25 | $93 |
| FY2023 Mr Richard Barasch | $2.27M | $2.05M | $2.44M | $19 | $92 |
| FY2023 Mr Stephen Griggs | $10.44M | $1.89M | $2.44M | $19 | $92 |
| FY2022 | $4.72M | $4.30M | $2.82M | $51 | $87 |
“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.
Executive compensation, fiscal 2025
Summary compensation table from the latest proxy statement
| Executive | Salary | Bonus | Stock awards | Incentive pay | Other | Total | vs. prior year |
|---|---|---|---|---|---|---|---|
| Suzanne Foster Chief Executive Officer | $1.00M | – | $7.53M | $1.39M | $330.67K | $10.26M | +22% |
| Jason Clemens Chief Financial Officer | $670.00K | – | $3.50M | $778.70K | $10.68K | $4.96M | -22% |
| Toby Scott Barnhart Chief Operating Officer | $600.00K | – | $1.75M | $697.35K | $516 | $3.05M | +126% |
| Russell Schuster Chief Commercial Officer | $450.00K | $100.00K | $1.89M | $523.01K | $8.46K | $2.97M | – |
| Albert Prast Chief Technology Officer | $450.00K | – | $1.75M | $523.01K | $1.61K | $2.72M | -5% |
Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.
IPO
From the final prospectus (Form 424B4) and the first day of trading
SPAC offering
- Type
- SPAC (blank check) IPO of units
- Final prospectus filed
- Feb 15, 2018
- Offer price
- $10.00
- Securities offered
- 25,000,000
- Gross proceeds
- $250.00M
- Exchange
- Nasdaq
- First trading day
- Apr 16, 2018
- First-day close
- $9.78-2.2%
- Lock-up ends (est.)
- Oct 13, 2018
“Each unit has an offering price of $10.00 and consists of one share of our common stock and one-third of one redeemable warrant.”
Lock-up end is estimated as 180 days after the first trading day; the prospectus sets the actual terms.
Employees
Headcount reported in annual reports
“As of December 31, 2025, AdaptHealth had approximately 10,900 employees.”
Corporate history
Events identified from SEC filings
See a number that looks wrong?